These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 32968485)
1. Amplification and clinicopathological significance of HER-2 in Kazakh esophageal squamous cell carcinoma. Muhetaer A; Niyaz M; Ainiwaer J; Liwei Z; Awut E Mol Clin Oncol; 2020 Nov; 13(5):64. PubMed ID: 32968485 [TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor protein overexpression and gene amplification are associated with aggressive biological behaviors of esophageal squamous cell carcinoma. Lin G; Sun XJ; Han QB; Wang Z; Xu YP; Gu JL; Wu W; Zhang GU; Hu JL; Sun WY; Mao WM Oncol Lett; 2015 Aug; 10(2):901-906. PubMed ID: 26622592 [TBL] [Abstract][Full Text] [Related]
3. Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas. Yang YL; Xu KL; Zhou Y; Gao X; Chen LR Chin Med J (Engl); 2012 Feb; 125(3):450-4. PubMed ID: 22490401 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of PLCE1 in Kazakh esophageal squamous cell carcinoma: implications in cancer metastasis and aggressiveness. Chen YZ; Cui XB; Hu JM; Zhang WJ; Li SG; Yang L; Shen XH; Liu CX; Pan QF; Yu SY; Yuan XL; Yang L; Gu WY; Chen JZ; Wang LD; Li F APMIS; 2013 Oct; 121(10):908-18. PubMed ID: 23659763 [TBL] [Abstract][Full Text] [Related]
5. HER2 gene amplification in esophageal squamous cell carcinoma is less than in gastroesophageal junction and gastric adenocarcinoma. Huang JX; Zhao K; Lin M; Wang Q; Xiao W; Lin MS; Yu H; Chen P; Qian RY Oncol Lett; 2013 Jul; 6(1):13-18. PubMed ID: 23946770 [TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of Kwon D; Yun JY; Keam B; Kim YT; Jeon YK World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804 [TBL] [Abstract][Full Text] [Related]
7. RANK overexpression as a novel esophageal cancer marker: validated immunohistochemical analysis of two different ethnicities. Cui X; Peng H; Jin J; Li T; Zhang S; Jin T; Li S; Liu C; Liang W; Li F; Chen Y Int J Clin Exp Pathol; 2015; 8(2):2249-58. PubMed ID: 25973136 [TBL] [Abstract][Full Text] [Related]
8. Association between TP53 gene deletion and protein expression in esophageal squamous cell carcinoma and its prognostic significance. Niyaz M; Ainiwaer J; Abudureheman A; Zhang L; Sheyhidin I; Turhong A; Cai R; Hou Z; Awut E Oncol Lett; 2020 Aug; 20(2):1855-1865. PubMed ID: 32724429 [TBL] [Abstract][Full Text] [Related]
9. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma]. Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216 [TBL] [Abstract][Full Text] [Related]
10. The increased number of tumor-associated macrophage is associated with overexpression of VEGF-C, plays an important role in Kazakh ESCC invasion and metastasis. Hu JM; Liu K; Liu JH; Jiang XL; Wang XL; Yang L; Chen YZ; Liu CX; Li SG; Cui XB; Zou H; Pang LJ; Zhao J; Qi Y; Liang WH; Yuan XL; Li F Exp Mol Pathol; 2017 Feb; 102(1):15-21. PubMed ID: 27939650 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of VEGF-C and MMP-9 predicts poor prognosis in Kazakh patients with esophageal squamous cell carcinoma. Li J; Xie Y; Wang X; Jiang C; Yuan X; Zhang A; Liu C; Pang L; Li F; Hu J PeerJ; 2019; 7():e8182. PubMed ID: 31824776 [TBL] [Abstract][Full Text] [Related]
12. Poor prognostic impact of FGF4 amplification in patients with esophageal squamous cell carcinoma. Huang J; Song Q; Wang H; Wang H; Xu C; Wang X; Jiang Z; Wang Y; Xu Y; Su J; Zeng H; Tan L; Zhu H; Jiang D; Hou Y Hum Pathol; 2018 Oct; 80():210-218. PubMed ID: 29936056 [TBL] [Abstract][Full Text] [Related]
13. [Expression and clinical significance of DAPK1 and CD147 in esophageal squamous cell carcinoma]. Wan Y; Wu XY Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):44-8. PubMed ID: 22490855 [TBL] [Abstract][Full Text] [Related]
14. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma. Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of lymph node metastasis in esophageal squamous cell carcinoma. Wang H; Deng F; Liu Q; Ma Y Pathol Res Pract; 2017 Jul; 213(7):842-847. PubMed ID: 28554754 [TBL] [Abstract][Full Text] [Related]
16. CEP3 and CEP17 DNA probe potential in the genetic diagnosis and prognostic prediction of esophageal squamous cell cancer. Niyaz M; Abdurahman A; Turghun A; Awut I Exp Ther Med; 2016 Apr; 11(4):1375-1380. PubMed ID: 27073452 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of HLA-G Is positively associated with Kazakh esophageal squamous cell carcinoma in Xinjiang, China. Hu J; Li L; Liu Y; Chen Y; Liu C; Liang W; Zhao J; Zou H; Cui X; Qi Y; Li L; Feng L Viral Immunol; 2013 Jun; 26(3):180-4. PubMed ID: 23772974 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma. Wei R; Shang Z; Leng J; Cui L J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma. Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817 [TBL] [Abstract][Full Text] [Related]
20. Further evidence for prognostic significance of epidermal growth factor receptor gene amplification in patients with esophageal squamous cell carcinoma. Kitagawa Y; Ueda M; Ando N; Ozawa S; Shimizu N; Kitajima M Clin Cancer Res; 1996 May; 2(5):909-14. PubMed ID: 9816249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]